Comments
Loading...
Hemostemix Analyst Ratings and Price Targets | OTC:HMTXF | Benzinga
Hemostemix Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Hemostemix Corp from these most-recent analyst ratings.
Analyst Ratings for Hemostemix
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for Hemostemix (HMTXF) stock?
There is no price target for Hemostemix
What is the most recent analyst rating for Hemostemix (HMTXF)?
There is no analyst for Hemostemix
When was the last upgrade for Hemostemix (HMTXF)?
There is no last upgrade for Hemostemix
When was the last downgrade for Hemostemix (HMTXF)?
There is no last downgrade for Hemostemix.
When is the next analyst rating going to be posted or updated for Hemostemix (HMTXF)?
There is no next analyst rating for Hemostemix.
Is the Analyst Rating Hemostemix (HMTXF) correct?
There is no next analyst rating for Hemostemix.
Browse analyst ratings and price targets on all stocks.